{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:10:55Z","timestamp":1793747455143,"version":"4.6.1"},"reference-count":30,"publisher":"Japanese Society of Internal Medicine","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2025,8,1]]},"DOI":"10.2169\/internalmedicine.4820-24","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T17:11:56Z","timestamp":1738948316000},"page":"2263-2269","source":"Crossref","is-referenced-by-count":2,"title":["Regional Difference of Liver Cancer in Japan: A Real-world Evidence Using the National Database of Health Insurance Claims"],"prefix":"10.2169","volume":"64","author":[{"given":"Masahito","family":"Nakano","sequence":"first","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Machiko","family":"Kawaguchi","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Nakano","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Sano","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Amano","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Liver Center, Saga University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunio","family":"Tarasawa","sequence":"additional","affiliation":[{"name":"Department of Health Administration and Policy, Tohoku University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Fujimori","sequence":"additional","affiliation":[{"name":"Department of Health Administration and Policy, Tohoku University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takumi","family":"Kawaguchi","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Ministry of Health, Labour and Welfare. VITAL STATISTICS OF JAPAN 2020 [Internet]. [updated 2022 Oct 26; cited 2020]. Available from: https:\/\/www.mhlw.go.jp\/toukei\/saikin\/hw\/jinkou\/houkoku20\/dl\/all.pdf"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Tanaka J, Akita T, Ko K, Miura Y, Satake M. Countermeasures against viral hepatitis B and C in Japan: an epidemiological point of view. Hepatol Res 49: 990-1002, 2019.","DOI":"10.1111\/hepr.13417"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Tateishi R, Okanoue T, Fujiwara N, et al. Clinical characteristics, treatment, and prognosis of non-B, non-C hepatocellular carcinoma: a large retrospective multicenter cohort study. J Gastroenterol 50: 350-360, 2015.","DOI":"10.1007\/s00535-014-0973-8"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Nakano M, Yatsuhashi H, Bekki S, et al. Trends in hepatocellular carcinoma incident cases in Japan between 1996 and 2019. Sci Rep 12: 1517, 2022.","DOI":"10.1038\/s41598-022-05444-z"},{"key":"5","unstructured":"5. Wang X, Zhang L, Dong B. Molecular mechanisms in MASLD\/MASH-related HCC. Hepatology. Forthcoming."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Phoolchund AGS, Khakoo SI. MASLD and the development of HCC: pathogenesis and therapeutic challenges. Cancers (Basel) 16: 2024.","DOI":"10.3390\/cancers16020259"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Enomoto H, Akuta N, Hikita H, et al. Etiological changes of liver cirrhosis and hepatocellular carcinoma-complicated liver cirrhosis in Japan: updated nationwide survey from 2018 to 2021. Hepatol Res 54: 763-772, 2024.","DOI":"10.1111\/hepr.14047"},{"key":"8","unstructured":"8. Rinella ME, Lazarus JV, Ratziu V, et al.; the NAFLD Nomenclature consensus group. A multi-society Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol 78: 1966-1986, 2023."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71: 209-249, 2021.","DOI":"10.3322\/caac.21660"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Ito T, Ishigami M, Zou B, et al. The epidemiology of NAFLD and lean NAFLD in Japan: a meta-analysis with individual and forecasting analysis, 1995-2040. Hepatol Int 15: 366-379, 2021.","DOI":"10.1007\/s12072-021-10143-4"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Nakano M, Kawaguchi M, Kawaguchi T. Almost identical values of various non-invasive indexes for hepatic fibrosis and steatosis between NAFLD and MASLD in Asia. J Hepatol 80: e155-e157, 2024.","DOI":"10.1016\/j.jhep.2023.12.030"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Tokushige K, Ikejima K, Ono M, et al. Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis 2020. J Gastroenterol 56: 951-963, 2021.","DOI":"10.1007\/s00535-021-01796-x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Tokushige K, Ikejima K, Ono M, et al. Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis 2020. Hepatol Res 51: 1013-1025, 2021.","DOI":"10.1111\/hepr.13688"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. ElSayed NA, Aleppo G, Aroda VR, et al. Addendum. 4. Comprehensive medical evaluation and assessment of comorbidities: Standards of Care in Diabetes - 2023. Diabetes Care 2023; 46 (Suppl. 1): S49-S67. Diabetes Care 46: 1718-1720, 2023.","DOI":"10.2337\/dc23-ad09"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Tamaki J, Fujimori K, Ikehara S, et al.; the Working Group of Japan Osteoporosis Foundation. Estimates of hip fracture incidence in Japan using the National Health Insurance Claim Database in 2012-2015. Osteoporos Int 30: 975-983, 2019.","DOI":"10.1007\/s00198-019-04844-8"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Nakayama T, Imanaka Y, Okuno Y, et al.; BiDAME: Big Data Analysis of Medical Care for the Eldely in Kyoto. Analysis of the evidence-practice gap to facilitate proper medical care for the elderly: investigation, using databases, of utilization measures for National Database of Health Insurance Claims and Specific Health Checkups of Japan (NDB). Environ Health Prev Med 22: 51, 2017.","DOI":"10.1186\/s12199-017-0644-5"},{"key":"17","unstructured":"17. Matsuda S, Fujimori K, Fushimi K, Ishikawa KB, Ikeda S. An analysis of the current state of home care in Japan using the Standardized Claim Ratio (SCR). Rev Jpn Soc Health Support Sci 3: 1-10, 2018."},{"key":"18","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12888-021-03657-6","volume":"22","author":"T Okui","year":"2022","unstructured":"18. Okui T, Park J. Analysis of regional differences in the amount of hypnotic and anxiolytic prescriptions in Japan using nationwide claims data. BMC Psychiatry 22: 44, 2022.","journal-title":"BMC Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/1471-244X","issn-type":"print"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Kodama T, Ida Y, Oshima K, Miura H. Are public oral care services evenly distributed? - Nation-wide assessment of the provision of oral care in Japan using the National Database of Health Insurance Claims. Int J Environ Res Public Health 18: 10850, 2021.","DOI":"10.3390\/ijerph182010850"},{"key":"20","unstructured":"20. Ministry of Health, Labour and Welfare [Internet]. Available from: https:\/\/www.mhlw.go.jp\/stf\/seisakunitsuite\/bunya\/0000177182.html"},{"key":"21","unstructured":"21. Health Insurance Claims Review & Reimbursement services [Internet]. Available from: https:\/\/www.ssk.or.jp\/seikyushiharai\/tensuhyo\/kihonmasta\/index.html"},{"key":"22","unstructured":"22. Stanford Program on International and Cross-Cultural Education [Internet]. Available from: https:\/\/spice.fsi.stanford.edu\/docs\/regions_of_japan?utm_source=chatgpt.com"},{"key":"23","unstructured":"23. Fujimori K. [Internet]. Available from: https:\/\/public.tableau.com\/app\/profile\/fujimori\/vizzes"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Enomoto H, Ueno Y, Hiasa Y, et al.; Japan Etiology of Liver Cirrhosis Study Group in the 54th Annual Meeting of JSH. The transition in the etiologies of hepatocellular carcinoma-complicated liver cirrhosis in a nationwide survey of Japan. J Gastroenterol 56: 158-167, 2021.","DOI":"10.1007\/s00535-020-01748-x"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Huang DQ, El-Serag HB, Loomba R. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol 18: 223-238, 2021.","DOI":"10.1038\/s41575-020-00381-6"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Kasuga M, Ueki K, Tajima N, et al. Report of the Japan Diabetes Society\/Japanese Cancer Association joint committee on diabetes and cancer. Cancer Sci 104: 965-976, 2013.","DOI":"10.1111\/cas.12203"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Facciorusso A. The influence of diabetes in the pathogenesis and the clinical course of hepatocellular carcinoma: recent findings and new perspectives. Curr Diabetes Rev 9: 382-386, 2013.","DOI":"10.2174\/15733998113099990068"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Arfianti E, Larter CZ, Lee S, et al. Obesity and diabetes accelerate hepatocarcinogenesis via hepatocyte proliferation independent of NF-\u03baB or Akt\/mTORC1. J Clin Transl Res 2: 26-37, 2016.","DOI":"10.18053\/jctres.02.201601.001"},{"key":"29","unstructured":"29. https:\/\/www.pref.kagawa.lg.jp\/kenkosomu\/yobou\/tounyounavi\/state.html"},{"key":"30","unstructured":"30. National Tax Agency. Alcoholic Beverage Sales (Consumption) per Adult in 2021 by Prefecture in Japan [Internet]. Available from: https:\/\/www.nta.go.jp\/taxes\/sake\/shiori-gaikyo\/shiori\/2021\/index.htm"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/15\/64_4820-24\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T04:16:36Z","timestamp":1754108196000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/15\/64_4820-24\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":30,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4820-24","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,1]]},"article-number":"4820-24"}}